Stay updated on Reslizumab in EGPA: Clinical Trial
Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest updates to the Reslizumab in EGPA: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe website has added new features, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check21 days agoChange DetectedSeveral key health-related links have been removed, including those related to granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis, which may impact access to important genetic and disease information.SummaryDifference0.7%
- Check28 days agoChange DetectedThe website has been updated to version 2.12.2, with numerous new links added related to granulomatosis with polyangiitis and other related conditions, while the previous version 2.12.1 has been removed.SummaryDifference5%
- Check36 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check43 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check65 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to Reslizumab in EGPA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.